Suppr超能文献

III型干扰素通常由细菌感应Toll样受体诱导产生,并在感染期间增强上皮屏障。

Type III IFNs Are Commonly Induced by Bacteria-Sensing TLRs and Reinforce Epithelial Barriers during Infection.

作者信息

Odendall Charlotte, Voak Andrew A, Kagan Jonathan C

机构信息

Harvard Medical School, Boston, MA 02115;

Division of Gastroenterology, Boston Children's Hospital, Boston, MA 02115; and.

出版信息

J Immunol. 2017 Nov 1;199(9):3270-3279. doi: 10.4049/jimmunol.1700250. Epub 2017 Sep 27.

Abstract

Type III IFNs (IFN-λs) are secreted factors that are well-known for their antiviral activities. However, their regulation and functions during bacterial infections are unclear. In this article, we report that the regulation of IFN-λ genes did not track with mechanisms that control type I IFN expression in response to TLRs. Whereas type I IFNs were only expressed from TLRs present on endosomes, type III IFNs could be induced by TLRs that reside at the plasma membrane and that detect various bacterial products. The mechanisms that regulate type III IFN gene expression tracked with those that promote inflammatory cytokine and chemokine expression. Importantly, rIFN-λs enhanced epithelial barriers in vitro, preventing transcellular bacteria dissemination. We therefore propose that in addition to their functions in cell-intrinsic antiviral immunity, type III IFNs protect epithelial barrier integrity, an activity that would benefit the host during any infectious encounter.

摘要

III型干扰素(IFN-λs)是一种分泌因子,以其抗病毒活性而闻名。然而,它们在细菌感染过程中的调控和功能尚不清楚。在本文中,我们报道IFN-λ基因的调控并不遵循控制I型干扰素表达以响应Toll样受体(TLRs)的机制。I型干扰素仅从内体上存在的TLRs表达,而III型干扰素可由位于质膜上并检测各种细菌产物的TLRs诱导。调节III型干扰素基因表达的机制与促进炎性细胞因子和趋化因子表达的机制一致。重要的是,重组IFN-λs在体外增强了上皮屏障,防止细菌跨细胞扩散。因此,我们提出,除了在细胞内抗病毒免疫中的功能外,III型干扰素还能保护上皮屏障的完整性,这一活性在任何感染过程中都将使宿主受益。

相似文献

1
Type III IFNs Are Commonly Induced by Bacteria-Sensing TLRs and Reinforce Epithelial Barriers during Infection.
J Immunol. 2017 Nov 1;199(9):3270-3279. doi: 10.4049/jimmunol.1700250. Epub 2017 Sep 27.
3
Type III and Not Type I Interferons Efficiently Prevent the Spread of Rotavirus in Human Intestinal Epithelial Cells.
J Virol. 2022 Sep 14;96(17):e0070622. doi: 10.1128/jvi.00706-22. Epub 2022 Aug 24.
4
Type III IFNs: Beyond antiviral protection.
Semin Immunol. 2019 Jun;43:101303. doi: 10.1016/j.smim.2019.101303.
5
Induction and regulation of IFNs during viral infections.
J Interferon Cytokine Res. 2004 Aug;24(8):439-54. doi: 10.1089/1079990041689665.
6
Importance of Type I and III Interferons at Respiratory and Intestinal Barrier Surfaces.
Front Immunol. 2020 Dec 11;11:608645. doi: 10.3389/fimmu.2020.608645. eCollection 2020.
8
Type I and Type III Interferons Differ in Their Adjuvant Activities for Influenza Vaccines.
J Virol. 2019 Nov 13;93(23). doi: 10.1128/JVI.01262-19. Print 2019 Dec 1.
9
Toll-like receptor expression and induction of type I and type III interferons in primary airway epithelial cells.
J Virol. 2013 Mar;87(6):3261-70. doi: 10.1128/JVI.01956-12. Epub 2013 Jan 9.
10
The interferon response to bacterial and viral infections.
J Endotoxin Res. 2006;12(4):246-50. doi: 10.1179/096805106X118799.

引用本文的文献

2
Interferons in health and disease.
Cell. 2025 Aug 21;188(17):4480-4504. doi: 10.1016/j.cell.2025.06.044.
3
Interferon Lambda: The Next Frontier in Antiviral Therapy?
Pharmaceuticals (Basel). 2025 May 24;18(6):785. doi: 10.3390/ph18060785.
5
Toll-like receptor signaling in teleosts.
Sci China Life Sci. 2025 Feb 14. doi: 10.1007/s11427-024-2822-5.
7
Typhimurium infection inhibits macrophage IFNβ signaling in a TLR4-dependent manner.
Infect Immun. 2024 Oct 15;92(10):e0009824. doi: 10.1128/iai.00098-24. Epub 2024 Sep 13.
8
Cell-intrinsic regulation of phagocyte function by interferon lambda during pulmonary viral, bacterial super-infection.
PLoS Pathog. 2024 Aug 23;20(8):e1012498. doi: 10.1371/journal.ppat.1012498. eCollection 2024 Aug.
10
In search of a function for human type III interferons: insights from inherited and acquired deficits.
Curr Opin Immunol. 2024 Apr;87:102427. doi: 10.1016/j.coi.2024.102427. Epub 2024 May 22.

本文引用的文献

2
Interferon-λ: Immune Functions at Barrier Surfaces and Beyond.
Immunity. 2015 Jul 21;43(1):15-28. doi: 10.1016/j.immuni.2015.07.001.
3
Noncanonical Effects of IRF9 in Intestinal Inflammation: More than Type I and Type III Interferons.
Mol Cell Biol. 2015 Jul;35(13):2332-43. doi: 10.1128/MCB.01498-14. Epub 2015 Apr 27.
4
Interferon-λ restricts West Nile virus neuroinvasion by tightening the blood-brain barrier.
Sci Transl Med. 2015 Apr 22;7(284):284ra59. doi: 10.1126/scitranslmed.aaa4304.
5
Innate immune pattern recognition: a cell biological perspective.
Annu Rev Immunol. 2015;33:257-90. doi: 10.1146/annurev-immunol-032414-112240. Epub 2015 Jan 2.
6
A role for the adaptor proteins TRAM and TRIF in toll-like receptor 2 signaling.
J Biol Chem. 2015 Feb 6;290(6):3209-22. doi: 10.1074/jbc.M114.593426. Epub 2014 Dec 11.
7
TRAM is required for TLR2 endosomal signaling to type I IFN induction.
J Immunol. 2014 Dec 15;193(12):6090-102. doi: 10.4049/jimmunol.1401605. Epub 2014 Nov 10.
8
SMOCs: supramolecular organizing centres that control innate immunity.
Nat Rev Immunol. 2014 Dec;14(12):821-6. doi: 10.1038/nri3757. Epub 2014 Oct 31.
9
Assembly and localization of Toll-like receptor signalling complexes.
Nat Rev Immunol. 2014 Aug;14(8):546-58. doi: 10.1038/nri3713.
10
Diverse intracellular pathogens activate type III interferon expression from peroxisomes.
Nat Immunol. 2014 Aug;15(8):717-26. doi: 10.1038/ni.2915. Epub 2014 Jun 22.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验